{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:32:46Z","timestamp":1773369166500,"version":"3.50.1"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1002\/smrj.56","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T15:30:11Z","timestamp":1433431811000},"page":"160-168","source":"Crossref","is-referenced-by-count":9,"title":["Nitrergic Mechanisms for Management of Recurrent Priapism"],"prefix":"10.1093","volume":"3","author":[{"given":"Uzoma A.","family":"Anele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1002\/smrj.56_bb0010","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J Urol"},{"key":"10.1002\/smrj.56_bb0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/00365599509180545","article-title":"Priapism, its incidence and seasonal distribution in Finland","volume":"29","author":"Kulmala","year":"1995","journal-title":"Scand J Urol Nephrol"},{"key":"10.1002\/smrj.56_bb0020","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","article-title":"Incidence of priapism in the general population","volume":"57","author":"Eland","year":"2001","journal-title":"Urology"},{"key":"10.1002\/smrj.56_bb0025","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2013.03.118","article-title":"Incidence of priapism in emergency departments in the United States","volume":"190","author":"Roghmann","year":"2013","journal-title":"J Urol"},{"key":"10.1002\/smrj.56_bb0030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications\u2014An international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int"},{"key":"10.1002\/smrj.56_bb0035","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archinte.1980.00330220022011","article-title":"Priapism and impotence in homozygous sickle cell disease","volume":"140","author":"Emond","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1002\/smrj.56_bb0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jsm.12816","article-title":"Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: Profile and risk factors","volume":"12","author":"Anele","year":"2015","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-5347(17)45549-2","article-title":"The ultrastructure of the erectile tissue in priapism","volume":"135","author":"Spycher","year":"1986","journal-title":"J Urol"},{"key":"10.1002\/smrj.56_bb0050","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-5347(17)65731-8","article-title":"Priapism; reasons for failure of therapy","volume":"83","author":"Hinman","year":"1960","journal-title":"J Urol"},{"key":"10.1002\/smrj.56_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1743-6109.2011.02317.x","article-title":"Priapism and sickle-cell anemia: Diagnosis and nonsurgical therapy","volume":"9","author":"Broderick","year":"2012","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.ijir.3900277","article-title":"Integrative erectile biology: The role of signal transduction and cell-to-cell communication in coordinating corporal smooth muscle tone and penile erection","volume":"9","author":"Christ","year":"1997","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.56_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0031-6997(24)01503-5","article-title":"Pharmacology of penile erection","volume":"53","author":"Andersson","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1002\/smrj.56_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1743-6109.2011.02288.x","article-title":"New insights into the pathophysiology of sickle cell disease-associated priapism","volume":"9","author":"Bivalacqua","year":"2012","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1152\/physrev.1995.75.1.191","article-title":"Physiology of penile erection","volume":"75","author":"Andersson","year":"1995","journal-title":"Physiol Rev"},{"key":"10.1002\/smrj.56_bb0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-5347(17)43911-5","article-title":"Mechanisms of venous occlusion during canine penile erection: An anatomic demonstration","volume":"137","author":"Fournier","year":"1987","journal-title":"J Urol"},{"key":"10.1002\/smrj.56_bb0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJM199201093260203","article-title":"Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission","volume":"326","author":"Rajfer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1002\/smrj.56_bb0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.1378650","article-title":"Nitric oxide: A physiologic mediator of penile erection","volume":"257","author":"Burnett","year":"1992","journal-title":"Science"},{"key":"10.1002\/smrj.56_bb0095","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1073\/pnas.052712499","article-title":"Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection","volume":"99","author":"Hurt","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/smrj.56_bb0100","doi-asserted-by":"crossref","first-page":"16624","DOI":"10.1073\/pnas.1213790109","article-title":"Cyclic AMP-dependent phosphorylation of neuronal nitric oxide synthase mediates penile erection","volume":"109","author":"Hurt","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/smrj.56_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0773.1990.tb00772.x","article-title":"Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: A unique transduction mechanism for transcellular signaling","volume":"67","author":"Ignarro","year":"1990","journal-title":"Pharmacol Toxicol"},{"key":"10.1002\/smrj.56_bb0110","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP phosphodiesterase-5: Target of sildenafil","volume":"274","author":"Corbin","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1002\/smrj.56_bb0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrurol.2011.28","article-title":"Priapism in hematological and coagulative disorders: An update","volume":"8","author":"Morrison","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1002\/smrj.56_bb0120","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.22195","article-title":"Sickle cell anemia and vascular dysfunction: The nitric oxide connection","volume":"224","author":"Akinsheye","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1002\/smrj.56_bb0125","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0407183102","article-title":"Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism","volume":"102","author":"Champion","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/smrj.56_bb0130","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.eururo.2006.10.061","article-title":"Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis","volume":"51","author":"Bivalacqua","year":"2007","journal-title":"Eur Urol"},{"key":"10.1002\/smrj.56_bb0135","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1111\/j.1743-6109.2009.01359.x","article-title":"Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism","volume":"6","author":"Bivalacqua","year":"2009","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0140","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1002\/smrj.56_bb0145","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1074\/jbc.274.8.4985","article-title":"Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling","volume":"274","author":"Houston","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1002\/smrj.56_bb0150","doi-asserted-by":"crossref","first-page":"15215","DOI":"10.1073\/pnas.221292098","article-title":"Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease","volume":"98","author":"Aslan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/smrj.56_bb0155","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1440-1681.2007.04639.x","article-title":"Sickle cell disease: Role of reactive oxygen and nitrogen metabolites","volume":"34","author":"Wood","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1002\/smrj.56_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.ijir.3900802","article-title":"Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters","volume":"14","author":"Lin","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.56_bb0165","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11934-012-0258-9","article-title":"Stuttering priapism: Insights into pathogenesis and management","volume":"13","author":"Morrison","year":"2012","journal-title":"Curr Urol Rep"},{"key":"10.1002\/smrj.56_bb0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1745-7262.2008.00314.x","article-title":"Insights of priapism mechanism and rationale treatment for recurrent priapism","volume":"10","author":"Yuan","year":"2008","journal-title":"Asian J Androl"},{"key":"10.1002\/smrj.56_bb0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2164\/jandrol.110.010934","article-title":"A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: Report of an international randomized control trial\u2014The priapism in sickle cell study","volume":"32","author":"Olujohungbe","year":"2011","journal-title":"J Androl"},{"key":"10.1002\/smrj.56_bb0180","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.juro.2009.06.040","article-title":"Ketoconazole and prednisone to prevent recurrent ischemic priapism","volume":"182","author":"Abern","year":"2009","journal-title":"J Urol"},{"key":"10.1002\/smrj.56_bb0185","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0090-4295(01)01492-3","article-title":"Antiandrogens in the treatment of priapism","volume":"59","author":"Dahm","year":"2002","journal-title":"Urology"},{"key":"10.1002\/smrj.56_bb0190","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(85)91555-7","article-title":"Stilboestrol and stuttering priapism in homozygous sickle-cell disease","volume":"2","author":"Serjeant","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/smrj.56_bb0195","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1743-6109.2005.00106.x","article-title":"Idiopathic stuttering priapism treated successfully with low-dose ethinyl estradiol: A single case report","volume":"2","author":"Shamloul","year":"2005","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0200","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00005392-199501000-00054","article-title":"Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue","volume":"153","author":"Steinberg","year":"1995","journal-title":"J Urol"},{"key":"10.1002\/smrj.56_bb0205","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jsm.12359","article-title":"Prevention of recurrent ischemic priapism with ketoconazole: Evolution of a treatment protocol and patient outcomes","volume":"11","author":"Hoeh","year":"2014","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0210","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.urology.2004.02.005","article-title":"Idiopathic stuttering priapism: Recovery of detumescence mechanism with temporal use of antiandrogen","volume":"63","author":"Yamashita","year":"2004","journal-title":"Urology"},{"key":"10.1002\/smrj.56_bb0215","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s11255-013-0583-z","article-title":"Prostate cancer risk after anti-androgen treatment for priapism","volume":"46","author":"Goetz","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1002\/smrj.56_bb0220","first-page":"47","article-title":"Molecular pathophysiology of priapism: Emerging targets","volume":"47","author":"Anele","year":"2014","journal-title":"Curr Drug Targets"},{"key":"10.1002\/smrj.56_bb0225","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1743-6109.2005.00094.x","article-title":"The physiological role of androgens in penile erection: Regulation of corpus cavernosum structure and function","volume":"2","author":"Traish","year":"2005","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0230","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1210\/en.2003-1699","article-title":"Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa","volume":"145","author":"Morelli","year":"2004","journal-title":"Endocrinology"},{"key":"10.1002\/smrj.56_bb0235","first-page":"209","article-title":"Nitric oxide mediated erectile activity is a testosterone dependent event: A rat erection model","volume":"7","author":"Zvara","year":"1995","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.56_bb0240","doi-asserted-by":"crossref","first-page":"e68028","DOI":"10.1371\/journal.pone.0068028","article-title":"Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative\/nitrosative stress","volume":"8","author":"Bivalacqua","year":"2013","journal-title":"PLoS One"},{"key":"10.1002\/smrj.56_bb0245","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1124\/mol.104.010678","article-title":"Erection capability is potentiated by long-term sildenafil treatment: Role of blood flow-induced endothelial nitric-oxide synthase phosphorylation","volume":"68","author":"Musicki","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1002\/smrj.56_bb0250","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/jsm.12391","article-title":"Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis","volume":"11","author":"Musicki","year":"2014","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0255","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.urology.2005.11.045","article-title":"Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism","volume":"67","author":"Burnett","year":"2006","journal-title":"Urology"},{"key":"10.1002\/smrj.56_bb0260","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1743-6109.2006.00333.x","article-title":"Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism","volume":"3","author":"Burnett","year":"2006","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0265","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1111\/j.1743-6109.2009.01285.x","article-title":"Oral phosphodiesterase type 5 inhibitors alleviate recurrent priapism complicating thalassemia intermedia: A case report","volume":"6","author":"Tzortzis","year":"2009","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0270","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2164\/jandrol.110.011890","article-title":"Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation","volume":"32","author":"Pierorazio","year":"2011","journal-title":"J Androl"},{"key":"10.1002\/smrj.56_bb0275","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","article-title":"Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease","volume":"127","author":"Burnett","year":"2014","journal-title":"Am J Med"},{"key":"10.1002\/smrj.56_bb0280","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"walk-PHaSST Investigators and Patients Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"key":"10.1002\/smrj.56_bb0285","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/smrj.56_bb0290","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell A, Follow-Up MSHP The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1002\/smrj.56_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.20142","article-title":"Follow-up of sickle cell disease patients with priapism treated by hydroxyurea","volume":"77","author":"Saad","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1002\/smrj.56_bb0300","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/00005392-199805000-00065","article-title":"Hydroxyurea in the treatment of sickle cell associated priapism","volume":"159","author":"Al Jam'a","year":"1998","journal-title":"J Urol"},{"key":"10.1002\/smrj.56_bb0305","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11255-014-0737-7","article-title":"Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: A case report and review of the literature","volume":"46","author":"Anele","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1002\/smrj.56_bb0310","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","article-title":"How I use hydroxyurea to treat young patients with sickle cell anemia","volume":"115","author":"Ware","year":"2010","journal-title":"Blood"},{"key":"10.1002\/smrj.56_bb0315","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood-2005-11-4454","article-title":"Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells","volume":"108","author":"Cokic","year":"2006","journal-title":"Blood"},{"key":"10.1002\/smrj.56_bb0320","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1365-2141.2002.03274.x","article-title":"Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease","volume":"116","author":"Gladwin","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1002\/smrj.56_bb0325","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2011.235","article-title":"Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: A randomized controlled trial","volume":"305","author":"Gladwin","year":"2011","journal-title":"JAMA"},{"key":"10.1002\/smrj.56_bb0330","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ajh.21832","article-title":"Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis","volume":"85","author":"Head","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1002\/smrj.56_bb0335","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000282844","article-title":"Effect of intracavernosal sodium nitroprusside in impotence","volume":"56","author":"Tarhan","year":"1996","journal-title":"Urol Int"},{"key":"10.1002\/smrj.56_bb0340","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0090-4295(94)80058-8","article-title":"Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction","volume":"44","author":"Truss","year":"1994","journal-title":"Urology"},{"key":"10.1002\/smrj.56_bb0345","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1096\/fj.13-228817","article-title":"Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism","volume":"28","author":"Lagoda","year":"2014","journal-title":"FASEB J"},{"key":"10.1002\/smrj.56_bb0350","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/HYPERTENSIONAHA.110.153536","article-title":"Inorganic nitrate supplementation lowers blood pressure in humans: Role for nitrite-derived NO","volume":"56","author":"Kapil","year":"2010","journal-title":"Hypertension"},{"key":"10.1002\/smrj.56_bb0355","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.107.103523","article-title":"Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite","volume":"51","author":"Webb","year":"2008","journal-title":"Hypertension"},{"key":"10.1002\/smrj.56_bb0360","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1515\/jpem-2012-0270","article-title":"Priapism in teenage boys following depot testosterone","volume":"25","author":"Donaldson","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1002\/smrj.56_bb0365","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.urology.2005.09.041","article-title":"Testosterone-induced priapism in Klinefelter syndrome","volume":"67","author":"Ichioka","year":"2006","journal-title":"Urology"},{"key":"10.1002\/smrj.56_bb0370","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/01.ju.0000049199.37765.c9","article-title":"Testosterone induced priapism in Kallmann's syndrome","volume":"169","author":"Shergill","year":"2003","journal-title":"J Urol"},{"key":"10.1002\/smrj.56_bb0375","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/jsm.12059","article-title":"Testosterone replacement with 1% testosterone gel and priapism: No definite risk relationship","volume":"10","author":"Burnett","year":"2013","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0380","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11255-014-0864-1","article-title":"Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease?","volume":"47","author":"Morrison","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1002\/smrj.56_bb0385","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.2047-2927.2013.00084.x","article-title":"Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report","volume":"1","author":"Morrison","year":"2013","journal-title":"Andrology"},{"key":"10.1002\/smrj.56_bb0390","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1096\/fj.13-248708","article-title":"Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells","volume":"28","author":"Fu","year":"2014","journal-title":"FASEB J"},{"key":"10.1002\/smrj.56_bb0395","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1464-410X.2006.06577.x","article-title":"Sialorphin (the mature peptide product of Vcsa1) relaxes corporal smooth muscle tissue and increases erectile function in the ageing rat","volume":"99","author":"Davies","year":"2007","journal-title":"BJU Int"},{"key":"10.1002\/smrj.56_bb0400","doi-asserted-by":"crossref","first-page":"C916","DOI":"10.1152\/ajpcell.00656.2008","article-title":"The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway","volume":"297","author":"Kanika","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1002\/smrj.56_bb0405","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1517\/14728222.10.3.445","article-title":"Nitric oxide\/redox-based signalling as a therapeutic target for penile disorders","volume":"10","author":"Burnett","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"10.1002\/smrj.56_bb0410","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1743-6109.2012.02798.x","article-title":"Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis","volume":"9","author":"Musicki","year":"2012","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0415","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.juro.2012.08.198","article-title":"Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis","volume":"189","author":"Lagoda","year":"2013","journal-title":"J Urol"},{"key":"10.1002\/smrj.56_bb0420","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ijir.2010.27","article-title":"Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue","volume":"22","author":"Kanika","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1002\/smrj.56_bb0425","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0090-4295(03)00484-9","article-title":"Reperfusion of ischemic corporal tissue: Physiologic and biochemical changes in an animal model of ischemic priapism","volume":"62","author":"Munarriz","year":"2003","journal-title":"Urology"},{"key":"10.1002\/smrj.56_bb0430","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1002\/smrj.56_bb0435","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/ATVBAHA.111.226803","article-title":"Adenosine signaling: Good or bad in erectile function?","volume":"32","author":"Wen","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/smrj.56_bb0440","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2125.1994.tb04366.x","article-title":"Adenosine modulation of neurotransmission in penile erection","volume":"38","author":"Chiang","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/smrj.56_bb0445","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI33467","article-title":"Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling","volume":"118","author":"Mi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1002\/smrj.56_bb0450","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1111\/j.1743-6109.2009.01552.x","article-title":"Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism","volume":"7","author":"Wen","year":"2010","journal-title":"J Sex Med"},{"key":"10.1002\/smrj.56_bb0455","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1096\/fj.11-181057","article-title":"A2B adenosine receptor contributes to penile erection via PI3K\/AKT signaling cascade-mediated eNOS activation","volume":"25","author":"Wen","year":"2011","journal-title":"FASEB J"},{"key":"10.1002\/smrj.56_bb0460","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1096\/fj.13-247833","article-title":"Excess adenosine A2B receptor signaling contributes to priapism through HIF-1alpha mediated reduction of PDE5 gene expression","volume":"28","author":"Ning","year":"2014","journal-title":"FASEB J"},{"key":"10.1002\/smrj.56_bb0465","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/83258","article-title":"Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway","volume":"7","author":"Chitaley","year":"2001","journal-title":"Nat Med"},{"key":"10.1002\/smrj.56_bb0470","doi-asserted-by":"crossref","first-page":"30614","DOI":"10.1074\/jbc.M204262200","article-title":"RhoA-mediated Ca2+ sensitization in erectile function","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1002\/smrj.56_bb0475","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.urology.2010.02.050","article-title":"Attenuated RhoA\/Rho-kinase signaling in penis of transgenic sickle cell mice","volume":"76","author":"Bivalacqua","year":"2010","journal-title":"Urology"},{"key":"10.1002\/smrj.56_bb0480","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1073\/pnas.0400520101","article-title":"RhoA\/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction","volume":"101","author":"Bivalacqua","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/smrj.56_bb0485","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2164\/jandrol.108.006999","article-title":"Posttranslational modification of constitutive nitric oxide synthase in the penis","volume":"30","author":"Musicki","year":"2009","journal-title":"J Androl"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052115301128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052115301128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T09:52:10Z","timestamp":1748425930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052115301128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2050052115301128"],"URL":"https:\/\/doi.org\/10.1002\/smrj.56","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}